fda compounding semaglutide news october 2025 A secret shopper study found that the majority of weight-loss clinics and medical spas in two states offered compounded tirzepatide and after shortages were resolved. Over half of the suppliers combined Compounding pharmacies to halt semaglutide

Medicare to start covering GLP-1 weight-loss therapies on July 1, 2026 May 2026 The Centers for Medicare & Medicaid Services (CMS) has launched the GLP-1 Bridge Program, a temporary initiative to provide coverage for effective weight-loss medications

Lanzkron S, Domm J, and Sweet K

It inhibits tyrosinase activity a key enzyme in melanin synthesis reducing existing pigmentation and preventing new discoloration

Conclusion:- Everyone has always desired flawless skin

However, novel promising combination therapies are being developed, including those that couple immunomodulators with drugs that stimulate -cell regeneration in order to restore normoglycaemia

doi: 10.3760/cma.j.issn.0366-6999.20113093 65 GullickNJAbozaidHSJayarajDMEvansHGScottDLChoyEHet al